HAS2 and ovarian cancer: Our TNMplot analysis of over 700 ovarian cancer specimens revealed that HAS1, HYAL1 and HYAL4 mRNA expression is significantly upregulated, whereas HAS2, HYAL2 and HYAL3 mRNA expression is significantly downregulated in ovarian cancer tissue compared to controls.